A phase 1b/2 study of nanatinostat and valganciclovir in patients with advanced Epstein-Barr virus positive (EBV+) solid tumors and in combination with pembrolizumab in patients with recurrent/metastatic nasopharyngeal carcinoma (RM-NPC).

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

Cytovene (ganciclovir) - Roche

Keytruda (pembrolizumab) - Merck (MSD)

nanatinostat (VRx-3996) - Viracta Therap

A. Dimitrios Colevas; Lillian L. Siu; Darren Wan-Teck Lim; Bo Gao; Lisa Rojkjaer; Afton Katkov; Yisrael Katz; Brigette Ma

Apr 28, 2022